The Uromigos
En podkast av The Uromigos
401 Episoder
-
Episode 363: 前立腺がんの最新の話題〜T cell directed therapyとradioligands〜
Publisert: 24.10.2024 -
Episode 362: 膀胱がんの最新の話題〜周術期薬物療法とADC〜
Publisert: 24.10.2024 -
Episode 361: The Role of Monotherapy AR Inhibition in Prostate Cancer
Publisert: 22.10.2024 -
Episode 360: The SUNRISE Program in Bladder Cancer
Publisert: 15.10.2024 -
Episode 359: #UromigosLive24 - IO after IO in RCC
Publisert: 9.10.2024 -
Episode 358: Noticias del Dia 1 de Uromigos Live 2024 en Nashville
Publisert: 30.9.2024 -
Episode 357: #UromigosLive24 - Peri-operative Therapy in Bladder Cancer
Publisert: 30.9.2024 -
Episode 356: #UromigosLive24 - Front-line Therapy in Papillary and Non-clear Cell RCC
Publisert: 28.9.2024 -
Episode 355: #UromigosLive24 - Radioligands in prostate cancer
Publisert: 28.9.2024 -
Episode 354: #UromigosLive24 - T cell directed therapy in prostate cancer
Publisert: 28.9.2024 -
Episode 353: #UromigosLive24 ADC session
Publisert: 28.9.2024 -
Episode 352: ESMO 2024 - RCC and Bladder review
Publisert: 23.9.2024 -
Episode 351: ESMO 2024 review part 1: prostate cancer
Publisert: 21.9.2024 -
Episode 350: ESMO 2024 - NIAGARA
Publisert: 16.9.2024 -
Episode 349: ESMO 2024 - Uromigos Japan!!
Publisert: 16.9.2024 -
Episode 348: ESMO 2024 - UpFrontPSMA
Publisert: 15.9.2024 -
Episode 347: ESMO 2024 - DV + Pembro in Urothelial Cancer
Publisert: 15.9.2024 -
Episode 346: ESMO 2024 - PEACE-3: Enza/Radium-223 vs Enza in mCRPC
Publisert: 14.9.2024 -
Episode 345: ESMO 2024 - SUNNIFORECAST: Ipi/Nivo vs SOC in Non-clear Cell RCC
Publisert: 14.9.2024 -
Episode 344: ESMO 2024 - NKT2152, a HIF inhibitor in RCC
Publisert: 14.9.2024
Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London
